Literature DB >> 29655446

Practical Anatomy of the Neuromuscular Junction in Health and Disease.

Hiroshi Nishimune1, Kazuhiro Shigemoto2.   

Abstract

Neuromuscular junctions (NMJs) form between nerve terminals of spinal cord motor neurons and skeletal muscles, and perisynaptic Schwann cells and kranocytes cap NMJs. One muscle fiber has one NMJ, which is innervated by one motor nerve terminal. NMJs are excitatory synapses that use P/Q-type voltage-gated calcium channels to release the neurotransmitter acetylcholine. Acetylcholine receptors accumulate at the postsynaptic specialization called the end plate on the muscle fiber membrane, the sarcolemma. Proteins essential for the organization of end plates include agrin secreted from nerve terminals, Lrp4 and MuSK receptors for agrin, and Dok-7 and rapsyn cytosolic proteins in the muscle.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylcholine receptors; Active zone; Motor neuron; MuSK; Muscle; Neuromuscular junction; Voltage-gated calcium channels

Mesh:

Year:  2018        PMID: 29655446      PMCID: PMC5903580          DOI: 10.1016/j.ncl.2018.01.009

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  60 in total

Review 1.  Basal lamina and the organization of neuromuscular synapses.

Authors:  Bruce L Patton
Journal:  J Neurocytol       Date:  2003 Jun-Sep

2.  Anti-MuSK antibodies: correlation with myasthenia gravis severity.

Authors:  E Bartoccioni; F Scuderi; G M Minicuci; M Marino; F Ciaraffa; A Evoli
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

Review 3.  Novel roles for collagens in wiring the vertebrate nervous system.

Authors:  Michael A Fox
Journal:  Curr Opin Cell Biol       Date:  2008-06-21       Impact factor: 8.382

4.  Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury.

Authors:  D M Valenzuela; T N Stitt; P S DiStefano; E Rojas; K Mattsson; D L Compton; L Nuñez; J S Park; J L Stark; D R Gies
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

Review 5.  Control of acetylcholine receptors in skeletal muscle.

Authors:  D M Fambrough
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

Review 6.  Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment.

Authors:  Yuji Yamanashi; Tohru Tezuka; Kazumasa Yokoyama
Journal:  J Biochem       Date:  2012-02-17       Impact factor: 3.387

7.  Clinical and experimental features of MuSK antibody positive MG in Japan.

Authors:  K Ohta; K Shigemoto; A Fujinami; N Maruyama; T Konishi; M Ohta
Journal:  Eur J Neurol       Date:  2007-09       Impact factor: 6.089

8.  Response to therapy in myasthenia gravis with anti-MuSK antibodies.

Authors:  Amelia Evoli; Maria R Bianchi; Raffaella Riso; Giacomo M Minicuci; Anna P Batocchi; Serenella Servidei; Flavia Scuderi; Emanuela Bartoccioni
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.

Authors:  Gil I Wolfe; Shin J Oh
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

View more
  9 in total

1.  A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Geroscience       Date:  2022-01-04       Impact factor: 7.581

2.  Barium chloride injures myofibers through calcium-induced proteolysis with fragmentation of motor nerves and microvessels.

Authors:  Aaron B Morton; Charles E Norton; Nicole L Jacobsen; Charmain A Fernando; D D W Cornelison; Steven S Segal
Journal:  Skelet Muscle       Date:  2019-11-06       Impact factor: 4.912

Review 3.  The Muscle Is Not a Passive Target in Myasthenia Gravis.

Authors:  Jean-Thomas Vilquin; Alexandra Clarissa Bayer; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Front Neurol       Date:  2019-12-19       Impact factor: 4.003

4.  Tks5 Regulates Synaptic Podosome Formation and Stabilization of the Postsynaptic Machinery at the Neuromuscular Junction.

Authors:  Marcin Pęziński; Kamila Maliszewska-Olejniczak; Patrycja Daszczuk; Paula Mazurek; Paweł Niewiadomski; Maria Jolanta Rędowicz
Journal:  Int J Mol Sci       Date:  2021-11-07       Impact factor: 5.923

Review 5.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

Review 6.  Recognising the potential of large animals for modelling neuromuscular junction physiology and disease.

Authors:  Stephen D Cahalan; Ines Boehm; Ross A Jones; Richard J Piercy
Journal:  J Anat       Date:  2022-09-02       Impact factor: 2.921

Review 7.  Sarcopenia: What Is the Origin of This Aging-Induced Disorder?

Authors:  Thomas Gustafsson; Brun Ulfhake
Journal:  Front Genet       Date:  2021-07-02       Impact factor: 4.599

Review 8.  Replace and repair: Biomimetic bioprinting for effective muscle engineering.

Authors:  Cooper Blake; Oliver Massey; Mitchell Boyd-Moss; Kate Firipis; Aaqil Rifai; Stephanie Franks; Anita Quigley; Robert Kapsa; David R Nisbet; Richard J Williams
Journal:  APL Bioeng       Date:  2021-07-08

Review 9.  The Nanoscopic Organization of Synapse Structures: A Common Basis for Cell Communication.

Authors:  Xiaojuan Yang; Wim Annaert
Journal:  Membranes (Basel)       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.